Randomized, double-blind, placebo-controlled clinical trial to evaluate mavacamten in adults with symptomatic non-obstructive hypertrophic cardiomyopathy
CLINICAL TRIAL WITH MEDICINES
Clinical trial information
- Promoter: MYOKARDIA, INC.
- Phase: III
- Execution start: 24/03/2023
- End of execution: 30/07/2025
- IP: JUAN JIMENEZ JAIMEZ
